Ben Diop


Success is to be measured not so much by the position that one has reached in life as by the obstacles which he has overcome while trying to succeed.- Booker T. Washington, Up From Slavery (1901)

Benjamin serves a range of life-science companies developing market opportunity assessments, global pricing and market access, therapeutic area, franchise, and product growth strategy, detailed forecasting, and market modeling.  Benjamin has particular experience leading projects in oncology where he has mainly focused on both hematologic disorders (CML, MF, MM) and solid tumors (Pancreatic, Lung, Breast, and Glioblastoma), cardiovascular diseases, and infectious diseases. He also has broad experience leading cases involving launch preparation, launch planning, and the associated development of a value story and access landscape. Prior to joining Putnam, Benjamin was a Life Science specialist at L.E.K. Consulting with a focus on the healthcare, pharmaceuticals, and med tech industries. He received a PhD from the joint Harvard – MIT Division of Health Sciences and Technology. Benjamin’s PhD research focused on drug delivery in tumors. Benjamin also received a B.Eng in Chemical Engineering from Vanderbilt University.

Strategy for the Life Sciences